PRF Technologies (PRFX) Exchange Rate Effect (2021 - 2023)
PRF Technologies (PRFX) posted quarterly Exchange Rate Effect of $7000.0 for Q4 2023, up 100.0% year-on-year from $3500.0 in Q4 2022, and up 450.0% on a QoQ basis from -$2000.0 in Q3 2023.
PRF Technologies (PRFX) Exchange Rate Effect (2021 - 2023) Analysis & Trends
PRF Technologies (PRFX) has reported Exchange Rate Effect for 3 consecutive years, with $7000.0 the latest figure, recorded in Q4 2023.
- Quarterly Exchange Rate Effect rose 100.0% year-over-year to $7000.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $2000.0 (changed N/A YoY) and the FY2025 annual result came in at -$2000.0, down 133.33% from the prior year.
- Exchange Rate Effect grew to $7000.0 in Q4 2023 per PRFX's latest filing, from -$2000.0 in the prior quarter.
- Over the last five years, Exchange Rate Effect for PRFX reached as high as $18.4 billion in Q3 2022 and fell as low as -$18.4 billion in Q4 2021.
- A 3-year average of -$2.3 billion and a median of -$2500.0 in 2023 frame the typical range for Exchange Rate Effect.
- The largest YoY upside for Exchange Rate Effect was 100.0% in 2023 against a maximum downside of 115.79% in 2023.
- Year by year, Exchange Rate Effect stood at -$18.4 billion in 2021, then changed by 0.0% to -$18.4 billion in 2022, then soared by 100.0% to $7000.0 in 2023.
- According to Business Quant data, Exchange Rate Effect over the past three periods registered $7000.0, -$2000.0, and -$3000.0 for Q4 2023, Q3 2023, and Q1 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | PRF Technologies | 745,168.93 | 451,168.93 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 7,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Mar 31, 2023 | -3,000.00 |
| Dec 31, 2022 | -18.37 Bn |
| Dec 31, 2022 | -18.37 Bn |
| Sep 30, 2022 | 18.37 Bn |
| Sep 30, 2022 | 18.37 Bn |
| Jun 30, 2022 | -19,000.00 |
| Jun 30, 2022 | -19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Mar 31, 2022 | 19,000.00 |
| Dec 31, 2021 | -18.37 Bn |
| Dec 31, 2021 | -18.37 Bn |